Evotec SE (EVO)
| Bid | 3.79 |
| Market Cap | 1.35B |
| Revenue (ttm) | 788.22M |
| Net Income (ttm) | -206.98M |
| EPS (ttm) | -0.67 |
| PE Ratio (ttm) | -5.69 |
| Forward PE | -66.17 |
| Analyst | Hold |
| Ask | 3.81 |
| Volume | 23,227 |
| Avg. Volume (20D) | 130,817 |
| Open | 3.79 |
| Previous Close | 3.76 |
| Day's Range | 3.73 - 3.82 |
| 52-Week Range | 2.84 - 5.64 |
| Beta | 1.09 |
Analyst Forecast
According to 0 analyst ratings, the average rating for EVO stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsNext Earnings Release
Analysts project revenue of ... Unlock content with Pro Subscription
1 month ago · accessnewswire.com
Evotec Receives $ 2.5 m Grant to Generate Next Generation Tuberculosis TreatmentsGates Foundation supports Evotec with a $ 2.5 M grant to generate critical data supporting development of next generation tuberculosis drug combinations. The collaboration continues a successful partn...
1 month ago · accessnewswire.com
Evotec SE Reports Q1 2025 results: Paving the Way for 2025 Growth in Soft Market EnvironmentGroup revenues of € 200 m, on track towards guidance; Shared R&D with similar trend as 2024; Just - Evotec Biologics with continuing growth momentum Strong progress in strategic protein degradation pa...
1 month ago · accessnewswire.com
Evotec SE to Announce Results for the First Quarter 2025 on 6 May 2025HAMBURG, DE / ACCESS Newswire / April 29, 2025 / Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809; NASDAQ: EVO) will announce its interim statement for the first quarter of 20...
2 months ago · accessnewswire.com
Evotec SE Unveils New Strategy and Provides 2025 Guidance Bolstered by Strong Q4 2024 ResultsEvotec sharpens focus on pioneering drug discovery and charts clear path toward sustainable profitable growth Strategy builds on technology and science leadership, focusing on high-growth, high-value ...
2 months ago · accessnewswire.com
Evotec SE to Announce Results for Financial Year 2024 on 17 April 2025HAMBURG, DE / ACCESS Newswire / April 10, 2025 / Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809; NASDAQ: EVO) will announce its financial results for 2024 on Thursday, 17 Ap...